<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"><channel><title>fluorouracil</title><link>http://www.unboundmedicine.com/medline/ebm/research/fluorouracil</link><description>Unbound MEDLINE is a service provided by Unbound Medicine, Inc. that includes data and services from the U.S. National Library of Medicine's MEDLINE® and PubMed® databases.</description><language>en-us</language><copyright>Unbound Medicine, Inc.</copyright><item><title>In vitro and in vivo evidence that a combination of lapatinib plus S-1 is a promising treatment for pancreatic cancer.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19925494/full_citation/In_vitro_and_in_vivo_evidence_that_a_combination_of_lapatinib_plus_S_1_is_a_promising_treatment_for_pancreatic_cancer_</link><description>Komoto M, Nakata B, Nishii T, et al. <br/><span class="title">In vitro and in vivo evidence that a combination of lapatinib plus S-1 is a promising treatment for pancreatic cancer. [JOURNAL ARTICLE]</span><br/><span class="source" title="Cancer science">Cancer Sci 2009 Oct 16.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19925494/abstract/In_vitro_and_in_vivo_evidence_that_a_combination_of_lapatinib_plus_S_1_is_a_promising_treatment_for_pancreatic_cancer_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19925494/full_citation/In_vitro_and_in_vivo_evidence_that_a_combination_of_lapatinib_plus_S_1_is_a_promising_treatment_for_pancreatic_cancer_">Full Citation</a></description></item><item><title>Synthesis and Preliminary Biological Evaluation of Chrysin Derivatives as Potential Anticancer Drugs.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19925447/full_citation/Synthesis_and_Preliminary_Biological_Evaluation_of_Chrysin_Derivatives_as_Potential_Anticancer_Drugs_</link><description>Zheng X, Zhao FF, Liu YM, et al. <br/><span class="title">Synthesis and Preliminary Biological Evaluation of Chrysin Derivatives as Potential Anticancer Drugs. [JOURNAL ARTICLE]</span><br/><span class="source" title="Medicinal chemistry (Shariqah (United Arab Emirates))">Med Chem 2009 Nov 18.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19925447/abstract/Synthesis_and_Preliminary_Biological_Evaluation_of_Chrysin_Derivatives_as_Potential_Anticancer_Drugs_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19925447/full_citation/Synthesis_and_Preliminary_Biological_Evaluation_of_Chrysin_Derivatives_as_Potential_Anticancer_Drugs_">Full Citation</a> | <a rel="nofollow" href="http://www.unboundmedicine.com/medline/ebm/related/19925447/Synthesis_and_Preliminary_Biological_Evaluation_of_Chrysin_Derivatives_as_Potential_Anticancer_Drugs_">Find Related Articles</a> </description></item><item><title>Salvage therapy with sorafenib plus vinblastine and fluorouracil for metastatic renal cell carcinoma.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19925379/full_citation/Salvage_therapy_with_sorafenib_plus_vinblastine_and_fluorouracil_for_metastatic_renal_cell_carcinoma_</link><description>Tai CJ <br/><span class="title">Salvage therapy with sorafenib plus vinblastine and fluorouracil for metastatic renal cell carcinoma. [JOURNAL ARTICLE]</span><br/><span class="source" title="Acta oncologica (Stockholm, Sweden)">Acta Oncol 2009; 48(6):931-932.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19925379/full_citation/Salvage_therapy_with_sorafenib_plus_vinblastine_and_fluorouracil_for_metastatic_renal_cell_carcinoma_">Full Citation</a></description></item><item><title>Pharmacotherapy of actinic keratosis.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19925043/full_citation/Pharmacotherapy_of_actinic_keratosis_</link><description>Berman B, Amini S, Valins W, et al. <br/><span class="title">Pharmacotherapy of actinic keratosis. [JOURNAL ARTICLE]</span><br/><span class="source" title="Expert opinion on pharmacotherapy">Expert Opin Pharmacother 2009 Nov 19.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19925043/abstract/Pharmacotherapy_of_actinic_keratosis_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19925043/full_citation/Pharmacotherapy_of_actinic_keratosis_">Full Citation</a> | <a rel="nofollow" href="http://www.unboundmedicine.com/medline/ebm/related/19925043/Pharmacotherapy_of_actinic_keratosis_">Find Related Articles</a> </description></item><item><title>The combination of 5-Fluorouracil plus p53 pathway restoration is associated with depletion of p53-deficient or mutant p53-expressing putative colon cancer stem cells.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19923910/full_citation/The_combination_of_5_Fluorouracil_plus_p53_pathway_restoration_is_associated_with_depletion_of_p53_deficient_or_mutant_p53_expressing_putative_colon_cancer_stem_cells_</link><description>Huang C, Zhang XM, Tavaluc RT, et al. <br/><span class="title">The combination of 5-Fluorouracil plus p53 pathway restoration is associated with depletion of p53-deficient or mutant p53-expressing putative colon cancer stem cells. [JOURNAL ARTICLE]</span><br/><span class="source" title="Cancer biology &amp; therapy">Cancer Biol Ther 2009 Nov 27; 8(22)</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19923910/abstract/The_combination_of_5_Fluorouracil_plus_p53_pathway_restoration_is_associated_with_depletion_of_p53_deficient_or_mutant_p53_expressing_putative_colon_cancer_stem_cells_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19923910/full_citation/The_combination_of_5_Fluorouracil_plus_p53_pathway_restoration_is_associated_with_depletion_of_p53_deficient_or_mutant_p53_expressing_putative_colon_cancer_stem_cells_">Full Citation</a> | <a rel="nofollow" href="http://www.unboundmedicine.com/medline/ebm/related/19923910/The_combination_of_5_Fluorouracil_plus_p53_pathway_restoration_is_associated_with_depletion_of_p53_deficient_or_mutant_p53_expressing_putative_colon_cancer_stem_cells_">Find Related Articles</a> </description></item><item><title>Cetuximab-Based Treatment of Metastatic Anal Cancer: Correlation of Response with KRAS Mutational Status.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19923868/full_citation/Cetuximab_Based_Treatment_of_Metastatic_Anal_Cancer:_Correlation_of_Response_with_KRAS_Mutational_Status_</link><description>Lukan N, Ströbel P, Willer A, et al. <br/><span class="title">Cetuximab-Based Treatment of Metastatic Anal Cancer: Correlation of Response with KRAS Mutational Status. [JOURNAL ARTICLE]</span><br/><span class="source" title="Oncology">Oncology 2009 Nov 17; 77(5):293-299.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19923868/abstract/Cetuximab_Based_Treatment_of_Metastatic_Anal_Cancer:_Correlation_of_Response_with_KRAS_Mutational_Status_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19923868/full_citation/Cetuximab_Based_Treatment_of_Metastatic_Anal_Cancer:_Correlation_of_Response_with_KRAS_Mutational_Status_">Full Citation</a></description></item><item><title>Can the 2-(13)C-uracil breath test be used to predict the effect of the antitumor drug S-1?</title><link>http://www.unboundmedicine.com/medline/ebm/record/19921195/full_citation/Can_the_2__13_C_uracil_breath_test_be_used_to_predict_the_effect_of_the_antitumor_drug_S_1</link><description>Ishii Y, Suzuki S, Takahashi Y, et al. <br/><span class="title">Can the 2-(13)C-uracil breath test be used to predict the effect of the antitumor drug S-1? [JOURNAL ARTICLE]</span><br/><span class="source" title="Cancer chemotherapy and pharmacology">Cancer Chemother Pharmacol 2009 Nov 18.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19921195/abstract/Can_the_2__13_C_uracil_breath_test_be_used_to_predict_the_effect_of_the_antitumor_drug_S_1">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19921195/full_citation/Can_the_2__13_C_uracil_breath_test_be_used_to_predict_the_effect_of_the_antitumor_drug_S_1">Full Citation</a> | <a rel="nofollow" href="http://www.unboundmedicine.com/medline/ebm/related/19921195/Can_the_2__13_C_uracil_breath_test_be_used_to_predict_the_effect_of_the_antitumor_drug_S_1">Find Related Articles</a> </description></item><item><title>Quality-of-life findings from a randomised phase-III study of XELOX vs FOLFOX-6 in metastatic colorectal cancer.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19920832/full_citation/Quality_of_life_findings_from_a_randomised_phase_III_study_of_XELOX_vs_FOLFOX_6_in_metastatic_colorectal_cancer_</link><description>Conroy T, Hebbar M, Bennouna J, et al. <br/><span class="title">Quality-of-life findings from a randomised phase-III study of XELOX vs FOLFOX-6 in metastatic colorectal cancer. [JOURNAL ARTICLE]</span><br/><span class="source" title="British journal of cancer">Br J Cancer 2009 Nov 17.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19920832/abstract/Quality_of_life_findings_from_a_randomised_phase_III_study_of_XELOX_vs_FOLFOX_6_in_metastatic_colorectal_cancer_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19920832/full_citation/Quality_of_life_findings_from_a_randomised_phase_III_study_of_XELOX_vs_FOLFOX_6_in_metastatic_colorectal_cancer_">Full Citation</a></description></item><item><title>Phase I/II study of sequential therapy with irinotecan and S-1 for metastatic colorectal cancer.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19920821/full_citation/Phase_I/II_study_of_sequential_therapy_with_irinotecan_and_S_1_for_metastatic_colorectal_cancer_</link><description>Yoshioka T, Kato S, Gamoh M, et al. <br/><span class="title">Phase I/II study of sequential therapy with irinotecan and S-1 for metastatic colorectal cancer. [JOURNAL ARTICLE]</span><br/><span class="source" title="British journal of cancer">Br J Cancer 2009 Nov 17.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19920821/abstract/Phase_I/II_study_of_sequential_therapy_with_irinotecan_and_S_1_for_metastatic_colorectal_cancer_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19920821/full_citation/Phase_I/II_study_of_sequential_therapy_with_irinotecan_and_S_1_for_metastatic_colorectal_cancer_">Full Citation</a> | <a rel="nofollow" href="http://www.unboundmedicine.com/medline/ebm/related/19920821/Phase_I/II_study_of_sequential_therapy_with_irinotecan_and_S_1_for_metastatic_colorectal_cancer_">Find Related Articles</a> </description></item><item><title>[Complete Remission with FLEP Chemotherapy for Multiple Liver Metastasis from Alpha-Fetoprotein-Producing Gastric Cancer-Report of a Case.]</title><link>http://www.unboundmedicine.com/medline/ebm/record/19920393/full_citation/[Complete_Remission_with_FLEP_Chemotherapy_for_Multiple_Liver_Metastasis_from_Alpha_Fetoprotein_Producing_Gastric_Cancer_Report_of_a_Case_]</link><description>Takahashi T, Kochi M, Kanamori N, et al. <br/><span class="title">[Complete Remission with FLEP Chemotherapy for Multiple Liver Metastasis from Alpha-Fetoprotein-Producing Gastric Cancer-Report of a Case.] [JOURNAL ARTICLE]</span><br/><span class="source" title="Gan to kagaku ryoho. Cancer &amp; chemotherapy">Gan To Kagaku Ryoho 2009 Nov; 36(11):1885-1888.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19920393/abstract/[Complete_Remission_with_FLEP_Chemotherapy_for_Multiple_Liver_Metastasis_from_Alpha_Fetoprotein_Producing_Gastric_Cancer_Report_of_a_Case_]">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19920393/full_citation/[Complete_Remission_with_FLEP_Chemotherapy_for_Multiple_Liver_Metastasis_from_Alpha_Fetoprotein_Producing_Gastric_Cancer_Report_of_a_Case_]">Full Citation</a></description></item></channel></rss>